Our scRNA-seq studies demonstrate that FGFR3 promotes luminal expression patterns across all urothelial cell types, verifying that FGFR inhibition has the ability to affect the majority of bladder tumor cells. Here, FGFR3 is linked to urinary bladder neoplasm.